Show simple item record

FieldValueLanguage
dc.contributor.authorBenfield, Camilla Toen
dc.contributor.authorMacKenzie, Farrellen
dc.contributor.authorRitzefeld, Markusen
dc.contributor.authorMazzon, Michelaen
dc.contributor.authorWeston, Stuarten
dc.contributor.authorTate, Edward Wen
dc.contributor.authorTeo, Boon Hanen
dc.contributor.authorSmith, Sarah Een
dc.contributor.authorKellam, Paulen
dc.contributor.authorHolmes, Edward C.en
dc.contributor.authorMarsh, Marken
dc.date.accessioned2020-05-27
dc.date.available2020-05-27
dc.date.issued2020en
dc.identifier.urihttps://hdl.handle.net/2123/22369
dc.description.abstractHost interferon-induced transmembrane proteins (IFITMs) are broad-spectrum antiviral restriction factors. Of these, IFITM3 potently inhibits viruses that enter cells through acidic endosomes, many of which are zoonotic and emerging viruses with bats (order Chiroptera) as their natural hosts. We previously demonstrated that microbat IFITM3 is antiviral. Here, we show that bat IFITMs are characterized by strong adaptive evolution and identify a highly variable and functionally important site—codon 70—within the conserved CD225 domain of IFITMs. Mutation of this residue in microbat IFITM3 impairs restriction of representatives of four different virus families that enter cells via endosomes. This mutant shows altered subcellular localization and reduced S-palmitoylation, a phenotype copied by mutation of conserved cysteine residues in microbat IFITM3. Furthermore, we show that microbat IFITM3 is S-palmitoylated on cysteine residues C71, C72, and C105, mutation of each cysteine individually impairs virus restriction, and a triple C71A-C72A-C105A mutant loses all restriction activity, concomitant with subcellular re-localization of microbat IFITM3 to Golgi-associated sites. Thus, we propose that S-palmitoylation is critical for Chiropteran IFITM3 function and identify a key molecular determinant of IFITM3 S-palmitoylation.en
dc.language.isoenen
dc.rightsOtheren
dc.subjectCOVID-19en
dc.subjectCoronavirusen
dc.titleBat IFITM3 restriction depends on S-palmitoylation and a polymorphic site within the CD225 domainen
dc.typeArticleen
dc.identifier.doi10.26508/lsa.201900542
dc.relation.otherAustralian Research Councilen
dc.relation.otherLeverhulme Trusten
dc.relation.otherMedical Research Councilen
dc.relation.otherEuropean Commissionen
dc.relation.otherCancer Research UKen
usyd.facultySeS faculties schools::Faculty of Scienceen


Show simple item record

Associated file/s

There are no files associated with this item.

Associated collections

Show simple item record

There are no previous versions of the item available.